Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

An expert discusses the therapeutic options included in the NCCN guidelines for metastatic castration-resistant prostate ...

Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

Researchers sought to assess barriers to and facilitators of first-line treatment intensification by physician practice setting and intensification frequency in mCSPC.

Melbourne-based scientists have, for the first time, discovered how to "switch off" a molecule which is one of the top ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...